Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
Over 3 Million Eye Drops Recalled Over Sterility Concerns
00

Over 3 Million Eye Drops Recalled Over Sterility Concerns

Apr 6, 2026

The U.S. Food and Drug Administration announced on April 6, 2026, a Class II recall of 3,111,072 bottles of over-the-counter eye drops manufactured by K.C. Pharmaceuticals of Pomona, California, due to lack of assurance of sterility. The recalled 0.5-ounce bottles include multiple formulations sold under names like Dry Eye Relief Eye Drops, Sterile Eye Drops, Artificial Tears, and Sterile Lubricant Eye Drops at major retailers including CVS, Walgreens, and Rite Aid. A Class II recall indicates the products could cause temporary or medically reversible health problems, though no injuries have been reported as of the announcement date. The cause of the sterility issue remains unclear.

Scope and Details of the Eye Drop Recall

  • ▪The K.C. Pharmaceuticals eye drop recall was issued due to a lack of assurance of sterility
  • ▪The recalled K.C. Pharmaceuticals eye drops include several types of 0.5-ounce (15 mL) bottles
  • ▪The U.S. Food and Drug Administration said the recall affects 3,111,072 bottles made by K.C. Pharmaceuticals of Pomona, California
  • ▪The K.C. Pharmaceuticals eye drop recall was announced on April 6, 2026
  • ▪Over 3 million bottles of over-the-counter eye drops are being recalled due to sterility concerns

Products Affected and Distribution Channels

  • ▪The recalled products include Dry Eye Relief Eye Drops containing glycerin 0.2%, hypromellose 0.2%, and polyethylene glycol 400 1% in 0.5 fl oz bottles
  • ▪The recalled K.C. Pharmaceuticals eye drops were available at major retailers including CVS, Walgreens, and Rite Aid
  • ▪The recalled K.C. Pharmaceuticals eye drops were sold under names including Dry Eye Relief Eye Drops, Sterile Eye Drops, Artificial Tears, and Sterile Lubricant Eye Drops
  • ▪The recalled products include Sterile Eye Drops AC containing tetrahydrozoline HCl 0.05% and zinc sulfate 0.25% in 0.5 fl oz bottles

Safety Classification and Health Risk Assessment

  • ▪The U.S. Food and Drug Administration classified the K.C. Pharmaceuticals eye drop recall as a Class II recall
  • ▪The cause of the sterility issue with the K.C. Pharmaceuticals eye drops is not yet clear
  • ▪There have been no reports of injuries linked to the recalled K.C. Pharmaceuticals eye drops as of April 6, 2026
  • ▪A Class II recall means the products could cause temporary or medically reversible health problems

Perspective of K.C. Pharmaceuticals

  • ▪K.C. Pharmaceuticals must retrieve 3,111,072 bottles of eye drops from retail distribution channels across the United States
  • ▪K.C. Pharmaceuticals faces regulatory scrutiny over its manufacturing processes that failed to ensure product sterility

Perspective of Major pharmacy retailers including CVS, Walgreens, and Rite Aid

  • ▪CVS, Walgreens, and Rite Aid must pull multiple K.C. Pharmaceuticals eye drop products from their store shelves nationwide
  • ▪Major pharmacy chains face potential customer service challenges handling returns of the recalled K.C. Pharmaceuticals eye drops

Perspective of Consumers who purchased the recalled eye drops

  • ▪Consumers who used the recalled K.C. Pharmaceuticals eye drops may have exposed their eyes to non-sterile products
  • ▪Purchasers of K.C. Pharmaceuticals eye drops should check their bottles against the recall list and discontinue use immediately
  • ▪Consumers face uncertainty about whether their use of the recalled eye drops will cause health complications

1 source

Medicalxpress
Over 3 million eye drops recalled amid sterility concerns
View source article

Story comments

Loading comments…

Topics

Drug Policy, Pricing & ApprovalDrug Approval and Clinical Trials